8 Results for "

X-ray structure

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "X-ray structure" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-109513
CAS No.: 107793-72-6
Pureté:  98.34%
Domaines de recherche:  

Others

Ioxilan is a low-osmolar, nonionic and tri-iodinated diagnostic contrast agent. Ioxilan is also an X-ray contrast agent for excretory urography and contrast enhanced computed tomographic (CECT) imaging of the head and body. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs .
loading...
    loading...
Cat. No.: HY-121125
CAS No.: 64274-28-8
Aucubigenin, the aglycone of the iridoid glycoside aucubin, has been characterized through X-ray diffraction analysis. Its crystal structure reveals monoclinic symmetry with specific conformations adopted by its cyclopentane and pyran rings. The study also determined the absolute configurations of both aucubin and aucubigenin. Significant O-H O hydrogen bonding interactions were observed in the crystal lattices of both compounds, highlighting their structural stability and potential for intermolecular interactions .
loading...
    loading...
Cat. No.: HY-111333
CAS No.: 105888-54-8
Synonyms: Dioxapyrrolomycin; LL-F42248α; AL-R2081
Target:  

Bacterial

Pyrroxamycin is a novel antibiotic produced by Streptomyces, whose chemical structure was determined by chemical properties and X-ray crystallography and 13C NMR spectroscopy analysis. It is active against Gram-positive bacteria and dermatophytes. In this paper, the authors discuss the taxonomy, fermentation, isolation, physicochemical properties, chemical structure, and biological activity of the strain producing Pyrroxamycin.
loading...
    loading...
Cat. No.: HY-125473
CAS No.: 1162665-52-2
Target:  

Endogenous Metabolite

Domaines de recherche:  

Infection

IDX375 is a novel non-nucleoside inhibitor with selective inhibitory activity against HCV NS5B. IDX375 has good selectivity for genotypes 1a and 1b. The structure and binding site of IDX375 were confirmed by X-ray cocrystal studies .
loading...
    loading...
Cat. No.: HY-106586A
CAS No.: 67992-58-9
Synonyms: P-286 sodium
Domaines de recherche:  

Cardiovascular Disease Cancer

Ioxaglate sodium (P-286 sodium) is an ionic, dimeric diagnostic contrast agent whose activity is mainly reflected in its ability to provide sufficient X-ray absorption to enhance visualization of blood vessels and other structures during imaging. Ioxaglate sodium is used to study the anatomical structure and functional status of cardiac vessels, especially in the diagnosis of coronary artery disease .
loading...
    loading...
Cat. No.: HY-P2138
CAS No.: 124020-62-8
Target:  

HIV Protease

Domaines de recherche:  

Others

U-85548E is an HIV protease inhibitor with nanomolar affinity for HIV-1 aspartic protease. By studying its structure-activity relationship, a potent nanomolar inhibitor with inhibitory effects on both HIV-1 and HIV-2 proteases was designed, and its binding mode was studied by X-ray crystallography and molecular modeling.
loading...
    loading...
Cat. No.: HY-120631A
CAS No.: 841302-51-0
Target:  

Dipeptidyl Peptidase

Domaines de recherche:  

Others

BMS-538305 hydrochloride is a potent and selective inhibitor of dipeptidyl peptidase IV (DPP-IV), exhibiting strong biological activity by forming a reversible covalent complex with the enzyme. BMS-538305 hydrochloride demonstrates its mechanism of action through the covalent attachment between the nitrile carbon of the inhibitor and the enzyme residue S630, as unveiled by the X-ray crystal structure analysis.
loading...
    loading...
Cat. No.: HY-109513R
CAS No.: 107793-72-6
Domaines de recherche:  

Others

Ioxilan (Standard) is the analytical standard of Ioxilan. This product is intended for research and analytical applications. Ioxilan is a low-osmolar, nonionic and tri-iodinated diagnostic contrast agent. Ioxilan is also an X-ray contrast agent for excretory urography and contrast enhanced computed tomographic (CECT) imaging of the head and body. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs .
loading...
    loading...